Found: 17
Select item for more details and to access through your institution.
Efficacy and safety of the PPAR[gamma] partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2011, v. 27, n. 4, p. 392, doi. 10.1002/dmrr.1187
- By:
- Publication type:
- Article
Healing of Diabetic Foot Ulcers in Patients Treated at the Copenhagen Wound Healing Center in 1999/2000 and in 2011/2012.
- Published in:
- Journal of Diabetes Research, 2019, p. 1, doi. 10.1155/2019/6429575
- By:
- Publication type:
- Article
Markers of Local Inflammation and Bone Resorption in the Acute Diabetic Charcot Foot.
- Published in:
- Journal of Diabetes Research, 2018, p. 1, doi. 10.1155/2018/5647981
- By:
- Publication type:
- Article
High Risk of Adrenal Insufficiency in Adults Previously Treated for Idiopathic Childhood Onset Growth Hormone Deficiency.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 12, p. 5784, doi. 10.1210/jc.2003-030529
- By:
- Publication type:
- Article
Abnormal Sympathoadrenal Activity, but Normal Energy Expenditure in Hypopituitarism.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 12, p. 5689, doi. 10.1210/jc.2003-030870
- By:
- Publication type:
- Article
Measurements of Body Composition by Dual-Energy X-ray Absorptiometry Improve Prediction of Energy Expenditure.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 904, n. 1, p. 79, doi. 10.1111/j.1749-6632.2000.tb06424.x
- By:
- Publication type:
- Article
Long-Term Changes in Sarcopenia and Body Composition in Diabetes Patients with and without Charcot Osteoarthropathy.
- Published in:
- Journal of Diabetes Research, 2022, p. 1, doi. 10.1155/2022/3142307
- By:
- Publication type:
- Article
Risk factors for development of nephropathy in patients with a diabetic Charcot foot.
- Published in:
- BMC Research Notes, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13104-021-05811-5
- By:
- Publication type:
- Article
Treatment of osteoporosis with denosumab in patients with decreased kidney function.
- Published in:
- Archives of Osteoporosis, 2023, v. 18, n. 1, p. 1, doi. 10.1007/s11657-023-01306-x
- By:
- Publication type:
- Article
Incidence rates of amputations in patients with diabetes in Denmark have been decreasing continuously for the last four decades, but further reduction is still needed.
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 11, p. 1, doi. 10.1111/dme.15413
- By:
- Publication type:
- Article
Are soft tissue composition of bone and non-bone pixels in spinal bone mineral measurements by DXA similar? Impact of weight loss.
- Published in:
- Clinical Physiology & Functional Imaging, 2002, v. 22, n. 1, p. 72, doi. 10.1046/j.1475-097x.2002.00398.x
- By:
- Publication type:
- Article
Long-term effects on the progress of neuropathy after diabetic Charcot foot: an 8.5-year prospective case–control study.
- Published in:
- BMC Research Notes, 2018, v. 11, p. 1, doi. 10.1186/s13104-018-3253-5
- By:
- Publication type:
- Article
Fractures and Osteoporosis in Patients With Diabetes With Charcot Foot.
- Published in:
- 2021
- By:
- Publication type:
- journal article
How Common Is the Rare Charcot Foot in Patients With Diabetes?
- Published in:
- 2021
- By:
- Publication type:
- Letter
The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
- Published in:
- Clinical Endocrinology, 2005, v. 62, n. 1, p. 18, doi. 10.1111/j.1365-2265.2004.02164.x
- By:
- Publication type:
- Article
Statistical error in pamidronate study?
- Published in:
- 2000
- By:
- Publication type:
- Letter